These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11997300)

  • 21. Is the Potable Water System an Advantageous Preinfection Niche for Bacteria Colonizing the Cystic Fibrosis Lung?
    Wargo MJ
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial contaminants in cosmetic products from a patient with cystic fibrosis.
    O'Gorman K; Xu J; Elborn JS; Boyle L; Millar BC; Goldsmith CE; Moore JE
    Br J Biomed Sci; 2006; 63(3):141-2. PubMed ID: 17058716
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS; Egan M; Kazmierczak BI
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.
    Nir M; Johansen HK; Høiby N
    Acta Paediatr; 1992 Dec; 81(12):1042-3. PubMed ID: 1283959
    [No Abstract]   [Full Text] [Related]  

  • 28. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of the controlled model of persisting infection , caused by Pseudomonas aeruginosa and bacteria of the complex Burkholderia cepacia].
    Chernukha MIu; Kovtun VP; Nikolaeva TN; Shaginian IA; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (2):14-20. PubMed ID: 15188552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential binding of mannose-binding lectin to respiratory pathogens in cystic fibrosis.
    Davies J; Neth O; Alton E; Klein N; Turner M
    Lancet; 2000 May; 355(9218):1885-6. PubMed ID: 10866448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interspecies biofilms of Pseudomonas aeruginosa and Burkholderia cepacia.
    Tomlin KL; Coll OP; Ceri H
    Can J Microbiol; 2001 Oct; 47(10):949-54. PubMed ID: 11718549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.
    Geisenberger O; Givskov M; Riedel K; Høiby N; Tümmler B; Eberl L
    FEMS Microbiol Lett; 2000 Mar; 184(2):273-8. PubMed ID: 10713433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial infections and inflammation in the lungs of cystic fibrosis patients.
    Conese M; Assael BM
    Pediatr Infect Dis J; 2001 Feb; 20(2):207-13. PubMed ID: 11224844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.